Breast Imaging Studies in Women at High Genetic Risk of Breast Cancer: Annual Follow-Up Study
Completed
200 enrolled
Clinical, Genetic, Behavioral, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Breast/Ovarian Cancer
Completed
377 enrolled
Breast Mammogram and Tissue Study
Completed
466 enrolled
BRCA Mutations in Latinas
Completed
266 enrolled
Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases
Phase 2 Completed
344 enrolled 11 charts
Removal of the Ovaries/Fallopian Tubes and CA-125 Screening to Reduce the Risk of Ovarian Cancer in Women at Increased Genetic Risk
Completed
40 enrolled
Risk Communication Within Mexican-American Families
Completed
498 enrolled
Testing the Drug Atezolizumab or Placebo With Usual Therapy in First-Line HER2-Positive Metastatic Breast Cancer
Phase 3 Completed
190 enrolled 12 charts
Endoxifen in Adults With Hormone Receptor Positive Solid Tumors
Phase 1 Completed
40 enrolled
Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed by Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery
Phase 2 Completed
454 enrolled 23 charts
Paclitaxel and Trastuzumab With or Without Lapatinib in Treating Patients With Stage II or Stage III Breast Cancer That Can Be Removed by Surgery
Phase 3 Completed
305 enrolled 10 charts
Veliparib With or Without Carboplatin in Treating Patients With Stage III or IV Breast Cancer
Phase 2 Completed
77 enrolled 17 charts
Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab With or Without Estrogen Deprivation in Treating Patients With Hormone Receptor-Positive, HER2-Positive Operable or Locally Advanced Breast Cancer
Phase 3 Completed
315 enrolled 11 charts
Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
Phase 3 Completed
3,270 enrolled 16 charts
An Exploratory Evaluation of Biomarkers in Blister Fluid in Healthy Volunteers and Irradiated Skin
Completed
61 enrolled
Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage IIIB or Stage IV Breast Cancer
Phase 3 Completed
394 enrolled 11 charts
Azacitidine and Entinostat in Treating Patients With Advanced Breast Cancer
Phase 2 Completed
58 enrolled 16 charts
Eligibility Screening for the NIH Intramural Research Program Clinical Protocols
Completed
19,522 enrolled
Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction
Phase 1 Completed
37 enrolled
Where Culture Meets Genetics: Exploring Latinas Causal Attributions of Breast and Colon Cancer and Models of Disease Inheritance
Completed
22 enrolled
Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data
Completed
484 enrolled
Is it Feasible?: Self-Affirmation for Hereditary Breast and Ovarian Cancer Genetic Counseling
Phase NA Completed
64 enrolled 23 charts
The Treatment of Stage I and II Carcinoma of the Breast With Mastectomy and Axillary Dissection Versus Excisional Biopsy, Axillary Dissection, and Definitive Irradiation
Phase 3 Completed
256 enrolled
Sorafenib in Treating Patients With Metastatic Breast Cancer
Phase 2 Completed
23 enrolled
Vaccine Therapy in Treating Patients With Metastatic Cancer
Phase 1 Completed
A Follow-up Study of Women Evaluated and Treated for Infertility
Completed
12,193 enrolled
Fulvestrant With or Without Bortezomib in Patients With Inoperable Locally Advanced or Metastatic Estrogen Receptor Positive Breast Cancer
Phase 2 Completed
118 enrolled 11 charts
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Phase 2 Completed
143 enrolled 24 charts
Alternative Dosing of Exemestane Before Surgery in Treating Postmenopausal Patients With Stage 0-II Estrogen Positive Breast Cancer
Phase 2 Completed
180 enrolled 46 charts
Follow-up Protocol for Patients With Cancer/AIDS/Skin Disease
Completed
1,031 enrolled
Olaparib and Onalespib in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Recurrent Ovarian, Fallopian Tube, Primary Peritoneal, or Triple-Negative Breast Cancer
Phase 1 Completed
28 enrolled 21 charts
High-Risk Breast Duct Epithelium
Completed
156 enrolled
Paclitaxel, Nab-paclitaxel, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer
Phase 3 Completed
799 enrolled 18 charts
Ad/HER2/Neu Dendritic Cell Cancer Vaccine Testing
Phase 1 Completed
33 enrolled 18 charts
T Cell Receptor Immunotherapy Targeting MAGE-A3 for Patients With Metastatic Cancer Who Are HLA-DP0401 Positive
Phase 1/2 Completed
21 enrolled 22 charts
Study of Docosahexaenoic Acid (DHA) in Triple Negative Breast Cancer Survivors
Phase 2 Completed
65 enrolled 11 charts
Self-Affirmation: Construct Validity
Completed
3,112 enrolled
T Cell Receptor Immunotherapy Targeting NY-ESO-1 for Patients With NY-ESO-1 Expressing Cancer
Phase 2 Completed
11 enrolled 12 charts
Tipifarnib and Combination Chemotherapy in Treating Patients With Stage II or Stage III Breast Cancer
Phase 1/2 Completed
60 enrolled 6 charts
Safety and Tolerability of a Modified Vaccinia Ankara (MVA)-Based Vaccine Modified to Express Brachyury and T-cell Costimulatory Molecules (MVA-Brachyury-TRICOM)
Phase 1 Completed
38 enrolled 20 charts
The Ultrasound Study of Tamoxifen
Completed
247 enrolled
Breast Imaging Studies in Women at High Genetic Risk of Breast Cancer: Menstrual Cycle Study
Completed
20 enrolled
Continuation of Follow-up of DES-Exposed Cohorts
Completed
10,805 enrolled
Molecular Profiling of Stage II and III Breast Cancer in Latin American Women Receiving Standard-of-Care Treatment
Completed
1,334 enrolled
Extended Follow-up of Columbia, MO Serum Bank Participants
Completed
6,720 enrolled
Multi-Targeted Recombinant Ad5 (CEA/MUC1/Brachyury) Based Immunotherapy Vaccine Regimen in People With Advanced Cancer
Phase 1 Completed
11 enrolled 18 charts
Doxorubicin Hydrochloride, Cyclophosphamide, and Pacltaxel With or Without Trastuzumab in Treating Women With HER2-Positive Node-Positive or High-Risk Node-Negative Breast Cancer
Phase 3 Completed
3,436 enrolled
A Prospective Cohort Study of Occupational Exposures and Cancer Risk Among Women
Completed
75,366 enrolled
Study of Health Effects of Cosmetic Breast Augmentation
Completed
17,424 enrolled
Intestine Bacteria and Breast Cancer Risk
Completed
175 enrolled